With CBG more difficult to source than CBD, Leafreport sought to find out whether this meant a lot of CBG products were on the market that didn't meet label claims listing the amount of the cannabinoid shoppers should expect to find inside.
Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production of CBG (cannabigerol), the first rare cannabinoid...
